WASHINGTON, D.C. — The FDA is warning five companies that their claims of curing opioid use and withdrawal are unfounded.
On June 30, the FDA sent letters to four companies selling kratom products and one company selling essential oils. All of the companies claimed treatment or cure of opioid use disorder and withdrawal symptoms.
The companies that got warnings are:
- Herbsens Botanicals
- Klarity Kratom
- Kratom Exchange
- Omni Consumer Products LLC d/b/a YoKratom
- MONQ, LLC
In the letters, the FDA warned the companies that the claims on their websites make the products considered drugs because they are intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease, and/or intended to affect the structure or any function of the body.
Read the full story at CBS4Indy.com
